1-3 of 3
Yoon-Koo Kang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies

Subject Area:
Gastroenterology , Oncology
Chia-Jui Yen, Masatoshi Kudo, Ho-Yeong Lim, Chih-Hung Hsu, Arndt Vogel, Giovanni Brandi, Rebecca Cheng, Ioana Simona Nitu, Paolo Abada, Yanzhi Hsu, Andrew X. Zhu, Yoon-Koo Kang
Journal: Liver Cancer
Liver Cancer (2020) 9 (4): 440–454.
https://doi.org/10.1159/000506946
Published Online: 05 May 2020
View article titled, Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies
Open the PDF for Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies in another window
Journal Articles

Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study

Subject Area:
Gastroenterology , Oncology
Masatoshi Kudo, Yoon-Koo Kang, Joong-Won Park, Shukui Qin, Yoshitaka Inaba, Eric Assenat, Yoshiko Umeyama, Maria José Lechuga, Olga Valota, Yosuke Fujii, Jean-Francois Martini, J. Andrew Williams, Shuntaro Obi
Journal: Liver Cancer
Liver Cancer (2018) 7 (2): 148–164.
https://doi.org/10.1159/000484620
Published Online: 29 May 2018
View article titled, Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study
Open the PDF for Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study in another window
Journal Articles

Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma

Subject Area:
Gastroenterology , Oncology
Jean-Luc Raoul, Joong-Won Park, Yoon-Koo Kang, Richard S Finn, Jun Suk Kim, Winnie Yeo, Blasé N Polite, Yee Chao, Ian Walters, Christine Baudelet, Riccardo Lencioni
Journal: Liver Cancer
Liver Cancer (2014) 3 (3-4): 439–450.
https://doi.org/10.1159/000343872
Published Online: 15 August 2014
View article titled, Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma
Open the PDF for Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma in another window